View Financial HealthSAS Florentaise 配当と自社株買い配当金 基準チェック /06SAS Florentaise配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesBoard Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Independent Director Damien Graton was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • May 17SAS Florentaise, Annual General Meeting, Jun 20, 2025SAS Florentaise, Annual General Meeting, Jun 20, 2025. Location: grand patis, saint mars du desert FranceReported Earnings • Mar 31First half 2024 earnings releasedFirst half 2024 results: €0.28 loss per share. Net loss: €2.27m (flat on 1H 2023).Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improves as stock rises 30%After last week's 30% share price gain to €2.32, the stock trades at a trailing P/E ratio of 34.9x. Average trailing P/E is 13x in the Chemicals industry in Germany.Valuation Update With 7 Day Price Move • Feb 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €1.89, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 12x in the Chemicals industry in Germany.New Risk • Nov 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Revenue has declined by 16% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (€24.6m market cap, or US$26.3m).Valuation Update With 7 Day Price Move • Nov 07Investor sentiment deteriorates as stock falls 33%After last week's 33% share price decline to €3.86, the stock trades at a trailing P/E ratio of 56.9x. Average trailing P/E is 11x in the Chemicals industry in Germany.Reported Earnings • Nov 02Full year 2023 earnings released: EPS: €0.07 (vs €0.49 in FY 2022)Full year 2023 results: EPS: €0.07 (down from €0.49 in FY 2022). Revenue: €54.5m (down 14% from FY 2022). Net income: €562.0k (down 80% from FY 2022). Profit margin: 1.0% (down from 4.5% in FY 2022).New Risk • Sep 22New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.9% operating cash flow to total debt). High level of non-cash earnings (21% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2022 fiscal period end). Market cap is less than US$100m (€54.0m market cap, or US$57.6m).New Risk • Sep 06New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.9% operating cash flow to total debt). High level of non-cash earnings (21% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2022 fiscal period end). Market cap is less than US$100m (€61.2m market cap, or US$65.6m).Board Change • May 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Damien Graton was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.決済の安定と成長配当データの取得安定した配当: QR0の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: QR0の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場SAS Florentaise 配当利回り対市場QR0 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (QR0)n/a市場下位25% (DE)1.5%市場トップ25% (DE)4.5%業界平均 (Chemicals)3.8%アナリスト予想 (QR0) (最長3年)n/a注目すべき配当: QR0は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: QR0は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: QR0の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: QR0が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 21:23終値2026/05/25 00:00収益2024/06/30年間収益2024/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋SAS Florentaise 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • May 20Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Independent Director Damien Graton was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • May 17SAS Florentaise, Annual General Meeting, Jun 20, 2025SAS Florentaise, Annual General Meeting, Jun 20, 2025. Location: grand patis, saint mars du desert France
Reported Earnings • Mar 31First half 2024 earnings releasedFirst half 2024 results: €0.28 loss per share. Net loss: €2.27m (flat on 1H 2023).
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improves as stock rises 30%After last week's 30% share price gain to €2.32, the stock trades at a trailing P/E ratio of 34.9x. Average trailing P/E is 13x in the Chemicals industry in Germany.
Valuation Update With 7 Day Price Move • Feb 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €1.89, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 12x in the Chemicals industry in Germany.
New Risk • Nov 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Revenue has declined by 16% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (€24.6m market cap, or US$26.3m).
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment deteriorates as stock falls 33%After last week's 33% share price decline to €3.86, the stock trades at a trailing P/E ratio of 56.9x. Average trailing P/E is 11x in the Chemicals industry in Germany.
Reported Earnings • Nov 02Full year 2023 earnings released: EPS: €0.07 (vs €0.49 in FY 2022)Full year 2023 results: EPS: €0.07 (down from €0.49 in FY 2022). Revenue: €54.5m (down 14% from FY 2022). Net income: €562.0k (down 80% from FY 2022). Profit margin: 1.0% (down from 4.5% in FY 2022).
New Risk • Sep 22New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.9% operating cash flow to total debt). High level of non-cash earnings (21% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2022 fiscal period end). Market cap is less than US$100m (€54.0m market cap, or US$57.6m).
New Risk • Sep 06New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.9% operating cash flow to total debt). High level of non-cash earnings (21% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2022 fiscal period end). Market cap is less than US$100m (€61.2m market cap, or US$65.6m).
Board Change • May 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Damien Graton was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.